Blueshift Asset Management, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
Blueshift Asset Management, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2022$162,000
-13.4%
11,523
-11.7%
0.03%
+58.8%
Q1 2022$187,000
-56.6%
13,052
-44.9%
0.02%
-66.7%
Q4 2020$431,000
-50.8%
23,680
-51.8%
0.05%
-57.1%
Q3 2020$876,000
-37.7%
49,081
-31.1%
0.12%
-25.6%
Q4 2019$1,405,000
+138.9%
71,217
+114.3%
0.16%
+107.8%
Q2 2019$588,000
-25.9%
33,232
-14.8%
0.08%
-30.6%
Q1 2019$794,00038,9910.11%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders